R-CODOX-M Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cyclophosphamide, vincristine, doxorubicin and high-dose methotrexate (CODOX-M) and rituximab that can be used in the treatment of non-Hodgkin lymphoma (NHL), including Burkitt lymphoma.

**Synonyms:** - CODOX-M-R - Cyclophosphamide/Doxorubicin/Methotrexate/Rituximab/Vincristine - Cyclophosphamide/Doxorubicin/Methotrexate/Rituximab/Vincristine Regimen - R-CODOX-M - R-CODOX-M - R-CODOX-M (rituximab-abbs) - R-CODOX-M (rituximab-arrx) - R-CODOX-M (rituximab-blit) - R-CODOX-M (rituximab-pvvr) - R-CODOX-M (rituximab-rite) - R-CODOX-M (rituximab-rixa) - R-CODOX-M (rituximab-rixi) - Rituxan/Cytoxan/Oncovin/Adriamycin/Methotrexate - Rituximab-Cyclophosphamide-Vincristine-Doxorubicin-Methotrexate - Rituximab/Cyclophosphamide/Oncovin/Doxorubicin/Methotrexate - Rituximab/Cyclophosphamide/Oncovin/Doxorubicin/Methotrexate Regimen